CEP
SRPT icon

Chicago Equity Partners’s Sarepta Therapeutics SRPT Stock Holding History

Chicago Equity Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,520
Closed -$777K – 968
2019
Q1 		$777K Hold
6,520
– – 0.03% 579
2018
Q4 		$712K Sell
6,520
-17,710
-73% -$2.21M 0.03% 554
2018
Q3 		$3.91M Buy
24,230
+6,895
+40% +$943K 0.12% 247
2018
Q2 		$2.29M Buy
17,335
+6,510
+60% +$614K 0.07% 360
2018
Q1 		$802K Buy
10,825
+535
+5% +$35.7K 0.03% 535
2017
Q4 		$573K Buy
+10,290
New +$545K 0.02% 594

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Equity Partners's SRPT Position: Q2 2019 in Review

Chicago Equity Partners sold out of Sarepta Therapeutics (SRPT) in Q2 2019, closing a stake of 6,520 shares — an estimated $777K sold.

Chicago Equity Partners first reported a position in SRPT in Q4 2017 and held it in 6 quarters. The position peaked at $3.91M in Q3 2018. 365 funds tracked by Wall St. Rank hold SRPT as of Q2 2019.

  • Chicago Equity Partners reported no remaining Sarepta Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 6,520 Sarepta Therapeutics shares in Q2 2019, an estimated $777K.
  • Chicago Equity Partners first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 6 quarters.
  • Chicago Equity Partners's Sarepta Therapeutics position peaked at $3.91M in Q3 2018.
  • 365 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2019.

Based on Chicago Equity Partners's 13F filing for Q2 2019, filed 2 Aug 2019.